Planet 13 Holdings (PLNH) Non-Current Debt (2021 - 2026)
Planet 13 Holdings (PLNH) posted quarterly Non-Current Debt of $1.2 million for Q1 2026, up 4.92% year-over-year from $1.2 million in Q1 2025, and up 1.23% quarter-over-quarter from $1.2 million in Q4 2025.
Planet 13 Holdings (PLNH) Non-Current Debt (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Non-Current Debt for 6 consecutive years, with $1.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Debt rose 4.92% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (up 4.92% YoY), while the FY2025 annual figure was $1.2 million, up 4.81% from the prior year.
- Non-Current Debt grew to $1.2 million in Q1 2026 per PLNH's latest filing, from $1.2 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $10.3 million in Q2 2024 and bottomed at $884000.0 in Q4 2022.
- Historically, Non-Current Debt has averaged $2.5 million across 5 years, with a median of $1.2 million in 2024.
- Annual changes were most pronounced in 2024 — Non-Current Debt surged 1068.74% — and 2025, when it tumbled 88.34%.
- Planet 13 Holdings' Non-Current Debt stood at $884000.0 in 2022, then changed by 0.0% to $884000.0 in 2023, then jumped by 33.23% to $1.2 million in 2024, then advanced by 4.81% to $1.2 million in 2025, then rose by 1.23% to $1.2 million in 2026.
- Business Quant data shows PLNH's Non-Current Debt at $1.2 million in Q1 2026, $1.2 million in Q4 2025, and $1.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | -8.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 12.09 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 27.73 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 11.61 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 3.85 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 130.00 Mn |
| 10 | Planet 13 Holdings | 52.64 Mn | 36.16 Mn | 12.32 Mn | 1.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.27 Mn |
| Mar 31, 2026 | 1.25 Mn |
| Dec 31, 2025 | 1.23 Mn |
| Jun 30, 2025 | 1.20 Mn |
| Mar 31, 2025 | 1.19 Mn |
| Dec 31, 2024 | 1.18 Mn |
| Sep 30, 2024 | 10.33 Mn |
| Jun 30, 2024 | 10.33 Mn |
| Mar 31, 2024 | 884,000.00 |
| Dec 31, 2023 | 884,000.00 |
| Sep 30, 2023 | 884,000.00 |
| Jun 30, 2023 | 884,000.00 |
| Mar 31, 2023 | 884,000.00 |
| Dec 31, 2022 | 884,000.00 |
| Dec 31, 2021 | 884,000.00 |